• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫细胞和癌细胞中 Toll 样受体激动剂、L-pampo 信号通路的基于网络的比较分析。

Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cells.

机构信息

MOGAM Institute for Biomedical Research, Seoul, 06730, Republic of Korea.

CHA Vaccine Institute, Seongnamsi, Gyenggido, 13488, South Korea.

出版信息

Sci Rep. 2024 Jul 26;14(1):17173. doi: 10.1038/s41598-024-67000-1.

DOI:10.1038/s41598-024-67000-1
PMID:39060412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11282102/
Abstract

Toll-like receptors (TLRs) are critical components to stimulate immune responses against various infections. Recently, TLR agonists have emerged as a promising way to activate anti-tumor immunity. L-pampo, a TLR1/2 and TLR3 agonist, induces humoral and cellular immune responses and also causes cancer cell death. In this study, we investigated the L-pampo-induced signals and delineated their interactions with molecular signaling pathways using RNA-seq in immune cells and colon and prostate cancer cells. We first constructed a template network with differentially expressed genes and influential genes from network propagation using the weighted gene co-expression network analysis. Next, we obtained perturbed modules using the above method and extracted core submodules from them by conducting Walktrap. Finally, we reconstructed the subnetworks of major molecular signals utilizing a shortest path-finding algorithm, TOPAS. Our analysis suggests that TLR signaling activated by L-pampo is transmitted to oxidative phosphorylation (OXPHOS) with reactive oxygen species (ROS) through PI3K-AKT and JAK-STAT only in immune and prostate cancer cells that highly express TLRs. This signal flow may further sensitize prostate cancer to L-pampo due to its high basal expression level of OXPHOS and ROS. Our computational approaches can be applied for inferring underlying molecular mechanisms from complex gene expression profiles.

摘要

Toll 样受体 (TLRs) 是刺激针对各种感染的免疫反应的关键组成部分。最近,TLR 激动剂已成为激活抗肿瘤免疫的一种有前途的方法。L-pampo 是 TLR1/2 和 TLR3 的激动剂,可诱导体液和细胞免疫反应,并导致癌细胞死亡。在这项研究中,我们使用免疫细胞和结肠和前列腺癌细胞中的 RNA-seq 研究了 L-pampo 诱导的信号,并阐明了它们与分子信号通路的相互作用。我们首先使用加权基因共表达网络分析,使用网络传播中的差异表达基因和有影响力的基因构建模板网络。接下来,我们使用上述方法获得了扰动模块,并通过 Walktrap 从中提取了核心子模块。最后,我们利用最短路径查找算法 TOPAS 重建了主要分子信号的子网。我们的分析表明,只有在高表达 TLR 的免疫和前列腺癌细胞中,L-pampo 激活的 TLR 信号通过 PI3K-AKT 和 JAK-STAT 传递到活性氧 (ROS) 的氧化磷酸化 (OXPHOS)。由于 OXPHOS 和 ROS 的基础表达水平较高,这种信号流可能使前列腺癌对 L-pampo 更加敏感。我们的计算方法可用于从复杂的基因表达谱中推断潜在的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/33e6428bb813/41598_2024_67000_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/c515553eba73/41598_2024_67000_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/89737e698204/41598_2024_67000_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/e09f1678cdc6/41598_2024_67000_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/df06d06197a0/41598_2024_67000_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/33e6428bb813/41598_2024_67000_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/c515553eba73/41598_2024_67000_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/89737e698204/41598_2024_67000_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/e09f1678cdc6/41598_2024_67000_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/df06d06197a0/41598_2024_67000_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af16/11282102/33e6428bb813/41598_2024_67000_Fig5_HTML.jpg

相似文献

1
Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cells.免疫细胞和癌细胞中 Toll 样受体激动剂、L-pampo 信号通路的基于网络的比较分析。
Sci Rep. 2024 Jul 26;14(1):17173. doi: 10.1038/s41598-024-67000-1.
2
Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.CpG 和聚肌苷酸:胞苷酸联合刺激单核细胞导致独特的信号激活,而单独的配体则观察不到这种激活。
Cell Signal. 2013 Nov;25(11):2246-54. doi: 10.1016/j.cellsig.2013.07.014. Epub 2013 Jul 19.
3
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.使用 TLR2/3 激动剂 L-pampo 进行肿瘤内免疫治疗可诱导强烈的抗肿瘤免疫反应,并增强免疫检查点阻断。
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2022-004799.
4
Combination of TLR1/2 and TLR3 ligands enhances CD4(+) T cell longevity and antibody responses by modulating type I IFN production.TLR1/2 和 TLR3 配体的联合通过调节 I 型 IFN 的产生增强 CD4(+)T 细胞的寿命和抗体应答。
Sci Rep. 2016 Sep 1;6:32526. doi: 10.1038/srep32526.
5
COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity.含TLR1/2和TLR3激动剂组合的COVID-19亚单位疫苗可诱导强大的保护性免疫。
Vaccines (Basel). 2021 Aug 27;9(9):957. doi: 10.3390/vaccines9090957.
6
Differential Effects of Toll-Like Receptor Signaling on the Activation of Immune Responses in the Upper Respiratory Tract.TLR 信号对呼吸道免疫反应激活的差异效应。
Microbiol Spectr. 2022 Feb 23;10(1):e0114421. doi: 10.1128/spectrum.01144-21.
7
TLR stimulation of prostate tumor cells induces chemokine-mediated recruitment of specific immune cell types.TLR 刺激前列腺肿瘤细胞诱导趋化因子介导的特定免疫细胞类型的募集。
J Immunol. 2010 Jun 15;184(12):6658-69. doi: 10.4049/jimmunol.0902401. Epub 2010 May 17.
8
Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.肿瘤进展位点2依赖性氧化爆发在Toll样受体3和9信号传导过程中驱动细胞外信号调节激酶的磷酸化。
J Biol Chem. 2014 Dec 26;289(52):36089-100. doi: 10.1074/jbc.M114.587121. Epub 2014 Nov 5.
9
Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists.用合成TLR 7激动剂刺激的浆细胞样树突状细胞中的转录网络
BMC Immunol. 2007 Oct 12;8:26. doi: 10.1186/1471-2172-8-26.
10
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells.PI3K/Akt 通路和自噬在 TLR3 信号诱导的人前列腺癌细胞凋亡和生长阻滞中的作用。
Cancer Immunol Immunother. 2012 May;61(5):667-76. doi: 10.1007/s00262-011-1132-1. Epub 2011 Oct 29.

引用本文的文献

1
Mammalian conservation of endogenous G-quadruplex reveals their associations with complex traits.哺乳动物内源性G-四链体的保守性揭示了它们与复杂性状的关联。
Genome Biol. 2025 Sep 1;26(1):262. doi: 10.1186/s13059-025-03750-z.
2
Toll-Like Receptors in the Immunotherapy Era: Dual-Edged Swords of Tumor Immunity and Clinical Translation.免疫治疗时代的Toll样受体:肿瘤免疫与临床转化的双刃剑
MedComm (2020). 2025 Jul 27;6(8):e70308. doi: 10.1002/mco2.70308. eCollection 2025 Aug.
3
The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity.

本文引用的文献

1
Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities.从高可信度的先验知识中扩展调控网络的覆盖范围,以准确估计转录因子的活性。
Nucleic Acids Res. 2023 Nov 10;51(20):10934-10949. doi: 10.1093/nar/gkad841.
2
Tat-malate dehydrogenase fusion protein protects neurons from oxidative and ischemic damage by reduction of reactive oxygen species and modulation of glutathione redox system.天冬氨酸苹果酸脱氢酶融合蛋白通过减少活性氧和调节谷胱甘肽氧化还原系统来保护神经元免受氧化和缺血损伤。
Sci Rep. 2023 Apr 6;13(1):5653. doi: 10.1038/s41598-023-32812-0.
3
Trial watch: Toll-like receptor ligands in cancer therapy.
模式识别受体在表观遗传和代谢重编程中的作用:对训练免疫的见解
J Inflamm Res. 2025 Jun 13;18:7795-7811. doi: 10.2147/JIR.S513325. eCollection 2025.
4
m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon.5-甲基胞嘧啶(m5C)甲基化修饰可能是结直肠癌逃避先天免疫I/III型干扰素抗肿瘤作用的帮凶。
Front Immunol. 2025 Jan 10;15:1512353. doi: 10.3389/fimmu.2024.1512353. eCollection 2024.
5
Regulating Immune Responses Induced by PEGylated Messenger RNA-Lipid Nanoparticle Vaccine.调控聚乙二醇化信使核糖核酸-脂质纳米颗粒疫苗诱导的免疫反应
Vaccines (Basel). 2024 Dec 27;13(1):14. doi: 10.3390/vaccines13010014.
研究观察: Toll 样受体配体在癌症治疗中的作用。
Oncoimmunology. 2023 Feb 17;12(1):2180237. doi: 10.1080/2162402X.2023.2180237. eCollection 2023.
4
Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma.纳武利尤单抗联合伊匹单抗对比舒尼替尼用于晚期肉瘤样肾细胞癌患者一线治疗的长期结局。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005445.
5
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
6
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.靶向前列腺癌中线粒体 OXPHOS 及其调控信号。
Int J Mol Sci. 2021 Dec 14;22(24):13435. doi: 10.3390/ijms222413435.
7
Nod-like Receptors: Critical Intracellular Sensors for Host Protection and Cell Death in Microbial and Parasitic Infections.Nod-like 受体:微生物和寄生虫感染中宿主保护和细胞死亡的关键细胞内传感器。
Int J Mol Sci. 2021 Oct 22;22(21):11398. doi: 10.3390/ijms222111398.
8
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
9
Damage-associated molecular patterns and Toll-like receptors in the tumor immune microenvironment.肿瘤免疫微环境中的损伤相关分子模式和 Toll 样受体。
Int Immunol. 2021 Nov 25;33(12):841-846. doi: 10.1093/intimm/dxab050.
10
Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy.靶向氧化磷酸化以提高放疗与免疫联合治疗的疗效
Clin Cancer Res. 2021 Jun 1;27(11):2970-2978. doi: 10.1158/1078-0432.CCR-20-3913. Epub 2021 Jan 8.